JSB Market Research : OpportunityAnalyzer: Non-Hodgkins B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 - PowerPoint PPT Presentation

About This Presentation
Title:

JSB Market Research : OpportunityAnalyzer: Non-Hodgkins B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

Description:

The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain and the UK is poised to undergo a dramatic shift during the forecast period. Disease management of the four largest B-cell NHL indications, which includes Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Marginal Zone Lymphoma (MZL), and Mantle Cell Lymphoma (MCL), currently revolves around multiple rounds of Rituxan-based chemotherapy. See full Report : – PowerPoint PPT presentation

Number of Views:64

less

Transcript and Presenter's Notes

Title: JSB Market Research : OpportunityAnalyzer: Non-Hodgkins B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018


1
OpportunityAnalyzer Non-Hodgkins B-Cell
Lymphoma - Opportunity Analysis and Forecast to
2018

To buy this Report Visit http//www.jsbm
arketresearch.com
  • p

2
Summary
  • The competitive landscape in the B-cell NHL
    markets in the US, France, Italy,
  • Germany, Spain and the UK is poised to undergo a
    dramatic shift during the
  • forecast period. Disease management of the four
    largest B-cell NHL
  • indications, which includes Diffuse Large B-Cell
    Lymphoma (DLBCL), Follicular
  • Lymphoma (FL), Marginal Zone Lymphoma (MZL), and
    Mantle Cell Lymphoma
  • (MCL), currently revolves around multiple rounds
    of Rituxan-based
  • chemotherapy.
  • p

3
Key Findings
  • Imbruvica will gain significant patient share in
    the relapsed/refractory MCL
  • market before expanding into the r/r FL setting.
    However, Zydeligs time-to
  • market advantage as well as potentially superior
    clinical profile in FL patients
  • will result in Zydelig maintaining the market
    lead in these patients.
  • There is significant opportunity for the new
    agents Imbruvica and Zydelig,
  • which are delivered orally and would greatly
    increase patient convenience in
  • addition to providing superior clinical benefit
    over chemoimmunotherapy
  • regimens.
  • p

4
Scope
  • Overview of B-cell NHL, including epidemiology,
    etiology, symptoms,
  • diagnosis, pathology and treatment guidelines for
    DLBCL, FL, MZL and MCL.
  • Annualized B-cell NHL (including DLBCL. FL. MZL
    and MCL) therapeutics
  • market revenue, annual cost of therapy and
    patient share in the first-line and
  • relapsed/refractory setting (as well as
    consolidation/maintenance for FL
  • patients) forecast from 2013 to 2018.
  • Key topics covered include strategic competitor
    assessment, market
  • characterization, unmet needs, clinical trial
    mapping and implications for the
  • B-cell NHL therapeutics market
  • p

5
Reasons to buy
  •  
  • Develop business strategies by understanding the
    trends shaping and driving
  • the B-cell NHL therapeutics markets in the US and
    5EU.
  • Drive revenues by understanding the key trends,
    innovative products and
  • technologies, market segments, and companies
    likely to impact the global
  • NHL therapeutics market in future.
  • To know more about this report click here
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r
  • OpportunityAnalyzer-Non-Hodgkins-B-Cell-Lymphoma-O
    pportunity
  • Analysis-and-Forecast-to-2018-123266
  • p

6
OpportunityAnalyzer Non-Hodgkins B-Cell Lymphoma
- Opportunity Analysis and Forecast to 2018
Disease Management
Unmet Needs Assessment and Opportunity Analysis 
Current Treatment Options
Disease Overview
  • p

7
Related Reports
  • CountryFocus Healthcare, Regulatory and
    Reimbursement
  • Landscape Australia
  • EpiCast Report Renal Cell Carcinoma -
    Epidemiology Forecast to 2023
  • Sickle Cell Disease Global Clinical Trials
    Review, H2, 2014
  •  Healthcare and Medical Market Research
  • p

8
About JSB Market Research
  • JSB MARKET RESEARCH is an online repository of an
    extensive collection of market research reports
    available online. This online portal contains
    high-quality reports with well-researched and
    high-quality content on a wide range of
    industries. These market research reports help us
    give a detailed insight into new opportunities in
    the industry, prevailing market trends,
    competitor analysis and future prospects.
  • JSBs reports are developed by the domain experts
    and publishers under a closely observed
    surveillance of industry specialists. Therefore,
    the researched data is well researched, well-
    organized and matching up to the best standards
    in the industry. Also JSBs database consists of
    detailed insights of the leading players in the
    global market, products and trends
  • p

9
Contact Us
  • Support General Inquiries
  • Mail support_at_jsbmarketresearch.com
    91 - 998 729 5242
  • Billing Support
  • Mail billing_at_jsbmarketresearch.com
    91 22 412 366 50
  • Website http//www.jsbmarketresearch.com
  • p
Write a Comment
User Comments (0)
About PowerShow.com